Therefore, certain differential genes expressed in tumor-infiltrating CD8+T cells of low-dose anti-angiogenesis combined immunotherapy group might be potentially responsible for the functional recovery of tumor-infiltrating exhausted CD8+T cells. Here, CD8A is linked to neoplasm.